Viewing Study NCT02259803


Ignite Creation Date: 2025-12-24 @ 7:38 PM
Ignite Modification Date: 2025-12-30 @ 3:43 PM
Study NCT ID: NCT02259803
Status: COMPLETED
Last Update Posted: 2014-10-09
First Post: 2014-10-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Relative Bioavailability of Telmisartan/Amlodipine Fixed-dose Combination Compared to Its Mono-components in Healthy Male Volunteers
Sponsor: Boehringer Ingelheim
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module